ALFA Filings
Every announcement, straight from the exchange
Every Ind-Swift Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
KMP Pardeep Verma sold 6,140 equity shares of Ind-Swift Laboratories Ltd via market sale, reducing his holding by 0.01%.
Ind-Swift Laboratories Ltd has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(c) of the SEBI Listing Regulations.
Ind-Swift Laboratories Limited submitted a nil statement of deviation or variation for funds raised through its preferential issue of convertible warrants for the quarter ended June 30, 2026.
Ind-Swift Laboratories Ltd has filed its quarterly shareholding pattern as of June 30, 2026, in compliance with SEBI regulatory requirements.
Ind-Swift Laboratories has re-appointed M/s. V Kumar & Associates as Cost Auditors for a 12-month term. This routine regulatory compliance ensures continued oversight of the company's cost records.